Recent advances in pelvic floor repair.
POP
SUI
gynaecology
incontinence
mesh
pelvic organ prolapse
prolapse
stress urinary incontinence
tissue engineering
urology
womens health
Journal
F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320
Informations de publication
Date de publication:
2019
2019
Historique:
accepted:
24
05
2019
entrez:
25
6
2019
pubmed:
25
6
2019
medline:
2
6
2020
Statut:
epublish
Résumé
Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are conditions which result in significant physical, mental and social consequences for women worldwide. The high rates of recurrence reported with primary repair for POP led to the use of synthetic mesh to augment repairs in both primary and secondary cases following failed previous POP repair. The widely reported, unacceptably high rates of complications associated with the use of synthetic, transvaginal mesh in pelvic floor repair have severely limited the treatment options that surgeons can offer. This article summarises the recent advances in pelvic floor repair, such as improved quantification and modelling of the biomechanics of the pelvic floor and the developing technology within the field of tissue engineering for treatment of SUI/POP, including biomaterials and cell-based therapies. Finally, we will discuss the issues surrounding the commercial introduction of synthetic mesh for use within the pelvic floor and what lessons can be learned for the future as well as the current guidance surrounding treatment for SUI/POP.
Identifiants
pubmed: 31231510
doi: 10.12688/f1000research.15046.1
pmc: PMC6556996
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
Competing interests: EM has received a grant from the Urology Foundation to undertake an MD in “The use of patients’ own fat derived cells to stimulate regeneration of the pelvic floor”. CC is an author for Allergen; received a grant, did a Scientific Study/Trial and is a researcher, author, meeting participant, speaker and consultant/advisor for Astellas; is a consultant/advisor for Bayer Schering Pharma AH, Ferring, Galvani Bioelectronics (GSK), Pierre Fabre, Tari Biomedical, Urovant Sciences; also a consultant/advisor and has a patent for Symimetics; did a Scientific Study/Trial and is a researcher for Ipsen; and is a meeting participant and speaker for Pfizer. SM has no competing interests.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.
Références
Sci Rep. 2017 Nov 23;7(1):16141
pubmed: 29170509
Stem Cell Res Ther. 2016 Apr 05;7(1):51
pubmed: 27048404
World J Stem Cells. 2016 May 26;8(5):202-15
pubmed: 27247705
Int Urogynecol J. 2017 Jul;28(7):999-1004
pubmed: 27900401
Am J Obstet Gynecol. 2016 Feb;214(2):260.e1-260.e8
pubmed: 26348376
Eur Urol Focus. 2019 Mar;5(2):280-289
pubmed: 28753895
BJU Int. 2013 Sep;112(5):674-85
pubmed: 23773418
N Z Vet J. 2014 Nov;62(6):328-37
pubmed: 24869753
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
J Biomed Mater Res B Appl Biomater. 2008 May;85(2):529-36
pubmed: 18161812
Neurourol Urodyn. 2014 Jun;33(5):531-7
pubmed: 23868812
Eur J Surg. 1998 Dec;164(12):965-9
pubmed: 10029393
Res Rep Urol. 2016 Jan 18;8:11-20
pubmed: 26848479
Int Urogynecol J. 2015 Apr;26(4):569-76
pubmed: 25335748
Int Urogynecol J. 2016 Aug;27(8):1255-63
pubmed: 26872644
Tissue Eng Part A. 2014 Feb;20(3-4):785-98
pubmed: 24083684
Stem Cell Res Ther. 2016 Nov 17;7(1):167
pubmed: 27855713
Stem Cell Res Ther. 2016 Oct 7;7(1):147
pubmed: 27717380
Tissue Eng Part A. 2016 Dec;22(23-24):1305-1316
pubmed: 27676643
J Biomed Opt. 2016 Dec 1;21(12):127008
pubmed: 28008450
Stem Cells Dev. 2016 Mar 15;25(6):453-61
pubmed: 26785911
Acta Biomater. 2016 Jan;29:188-197
pubmed: 26478470
Am J Obstet Gynecol. 2015 Apr;212(4):474.e1-8
pubmed: 25446700
BJU Int. 2011 Oct;108(8):1240-7
pubmed: 21883823
Acta Biomater. 2017 Jul 15;57:324-333
pubmed: 28487243
Exp Mol Med. 2013 Nov 15;45:e54
pubmed: 24232253
Biotechnol Adv. 2010 May-Jun;28(3):325-47
pubmed: 20100560
J Formos Med Assoc. 2014 Oct;113(10):704-15
pubmed: 23791005
Fed Regist. 2016 Jan 5;81(2):353-61
pubmed: 26742182
Stem Cells. 2010 Aug;28(8):1446-55
pubmed: 20597105
Acta Biomater. 2014 Dec;10(12):5012-5020
pubmed: 25194931
Compr Rev Food Sci Food Saf. 2010 Sep;9(5):552-571
pubmed: 33467829
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jun;18(6):603-7
pubmed: 17024520
Biomed Res Int. 2014;2014:853610
pubmed: 25136633
JAMA. 2013 May 15;309(19):2016-24
pubmed: 23677313
Eur Urol. 2017 Sep;72(3):424-431
pubmed: 28413126
Curr Opin Urol. 2017 May;27(3):262-267
pubmed: 28267057
Nat Rev Urol. 2018 Apr;15(4):197-198
pubmed: 29359737
Curr Urol Rep. 2014 Aug;15(8):425
pubmed: 24993035
Int Urogynecol J. 2018 Jun;29(6):847-858
pubmed: 29167974
BJOG. 2008 Jan;115(2):226-33
pubmed: 17970791
BMJ Open. 2011 Nov 14;1(2):e000206
pubmed: 22102637
PLoS One. 2016 Mar 16;11(3):e0149971
pubmed: 26981860
J Mech Behav Biomed Mater. 2017 Oct;74:349-357
pubmed: 28668592
BMJ Open. 2017 Dec 6;7(12):e017125
pubmed: 29212782
Eur Urol. 2013 Oct;64(4):525-9
pubmed: 23856039
Int Urogynecol J. 2015 Mar;26(3):401-6
pubmed: 25352072
J Urol. 2016 Jul;196(1):261-9
pubmed: 26880411
Eur Urol. 2009 May;55(5):1235-6
pubmed: 19645092
Biomaterials. 2017 Jan;112:95-107
pubmed: 27760399
Proc Inst Mech Eng H. 2014 Sep;228(9):867-75
pubmed: 25313023
Female Pelvic Med Reconstr Surg. 2020 Oct;26(10):607-611
pubmed: 30335649
Plast Reconstr Surg. 2012 Nov;130(5 Suppl 2):242S-253S
pubmed: 23096979
Acta Biomater. 2015 Feb;13:286-94
pubmed: 25462845
Int J Mol Med. 2016 Jul;38(1):95-104
pubmed: 27221348
Neurourol Urodyn. 2018 Feb;37(2):716-725
pubmed: 29439287
Eur J Surg. 1999 Jul;165(7):665-73
pubmed: 10452261